naftifine has been researched along with oxiconazole in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cauwenbergh, G | 1 |
Ablon, G; Rosen, T; Spedale, J | 1 |
Lucky, AW; Ploysangam, T | 1 |
Orengo, I; Rosen, T; Schell, BJ | 1 |
1 review(s) available for naftifine and oxiconazole
Article | Year |
---|---|
Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature.
Topics: Allylamine; Antifungal Agents; Child; Child, Preschool; Ciclopirox; Coloring Agents; Female; Foot Dermatoses; Humans; Hydroxides; Imidazoles; Ketoconazole; Male; Mycology; Onychomycosis; Potassium Compounds; Pyridones; Tinea Pedis; Trichophyton | 1997 |
2 trial(s) available for naftifine and oxiconazole
Article | Year |
---|---|
Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Allylamine; Antifungal Agents; Epidermophyton; Follow-Up Studies; Humans; Imidazoles; Male; Microsporum; Middle Aged; Naphthalenes; Ointments; Remission Induction; Single-Blind Method; Terbinafine; Tinea Pedis; Trichophyton | 1996 |
Anti-inflammatory activity of antifungal preparations.
Topics: Adult; Allylamine; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Chemoprevention; Ciclopirox; Double-Blind Method; Econazole; Erythema; Female; Humans; Hydrocortisone; Imidazoles; Ketoconazole; Male; Middle Aged; Naphthalenes; Pyridones; Terbinafine; Ultraviolet Rays | 1997 |
2 other study(ies) available for naftifine and oxiconazole
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |